ARCHIVES

Cancer Organizations Continue Reform Lobbying: Target Issue Are Off-Label Drugs, Clinical Trials

This article is from The Cancer Letter archive.

Vol. 19 No. 13 | March 26, 1993

Download PDF Visit The Full Archive

Related Articles

“5 A Day” Review Underway to Check Program’s Health at NCI.

March 31, 2000

FDA Approves NDA for Sodium Fluoride F18

February 4, 2011

Drug Shortages Reach All-Time High—Ben Venue Exit Will Make Problem Worse

October 11, 2013

Congress Approves FY 1980 HEW Funds

November 23, 1979

In Brief: Leonidas Platanias named director of Lurie Comprehensive Cancer Center

October 3, 2014

DCE Advisors Okay Study Of Cancer Risk in Breast Augmentation

November 22, 1991